RBC Capital analyst Craig Wong-Pan downgraded ResMed (NYSE: RMD) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst PT Change Downgrades

CLSA Downgrades ResMed (RMD:AU) (RMD) to Outperform (2), 'High near-term expectations may detract from long-term tailwinds'August 15, 2022 6:31 AM JPMorgan Downgrades ResMed (RMD) to NeutralAugust 12, 2022 9:38 AM